ニュース

404

PRISM BioLab、製薬大手のRoche社と Genentech社に対し独自開発のペプチド模倣技術を用いた低分子ライブラリーを提供

株式会社PRISM BioLab、エーザイ株式会社より資金調達

PRISM BioLab, the Japan based biotechnology company with proprietary small molecule drug discovery technology ”PepMetics®”, today announced that it has raised ¥100 million in Series C funding through a third-party allotment to Eisai Co. Ltd. on October 14. PRISM has completed the series C financing of 1.4 billion yen in total and aims to achieve...

Scroll to top
jaJapanese